08049.HK
Jilin Province Huinan Changlong Bio-pharmacy Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 2.38
+2.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.05x
- PEG TTM
- 0.46x
- Price / book
- 0.63x
- Price / sales
- 1.03x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- HKD 275.9M
- EV / sales
- 0.21x
- EV / EBITDA
- 0.63x
- EV / EBIT
- 0.69x
- Market cap
- HKD 1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026